Lv11
58 积分 2024-11-13 加入
The treatment of marginal zone lymphoma
4天前
已完结
Drug development in MZL: caring for the forgotten child
4天前
求助中
A real-world pharmacovigilance study of tafasitamab: data mining of the US food and drug administration adverse event reporting system
21天前
已完结
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
1个月前
已完结
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
1个月前
已完结
Real-World Outcomes with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective Study
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma
2个月前
已完结
Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline
2个月前
已完结
Hemophagocytic lymphohistiocytosis in adults
2个月前
已完结
皖公网安备34019202002308
